Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases

Current therapy for leishmaniasis is unsatisfactory. Efficacious and safe oral therapy would be ideal. We examined the efficacy of SCH 56592, an investigational triazole antifungal agent, against cutaneous infection with Leishmania amazonensis and visceral infection with Leishmania donovani in BALB/...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Al-Abdely, Hail M., Graybill, John R., Loebenberg, David, Melby, Peter C.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 1999
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC89586/
https://ncbi.nlm.nih.gov/pubmed/10582881
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы